Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score.

Literature DB >> 12922969

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score.

G Valentini, S D'Angelo, A Della Rossa, W Bencivelli, S Bombardieri.

Abstract

Entities: Disease

Mesh：

Year: 2003 PMID： 12922969 PMCID： PMC1754659 DOI： 10.1136/ard.62.9.904

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

Keyword Cloud
Cited

× No keyword cloud information.

25 in total

Review 1. My approach to the treatment of scleroderma.

Authors: Ami A Shah; Fredrick M Wigley
Journal: Mayo Clin Proc Date: 2013-04 Impact factor: 7.616

Review 2. [Autologous stem cell transplantation in systemic sclerosis].

Authors: J C Henes; S Wirths; I Kötter
Journal: Z Rheumatol Date: 2016-10 Impact factor: 1.372

3. B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial.

Authors: Silvia Bosello; Maria De Santis; Gina Lama; Cristina Spanò; Cristiana Angelucci; Barbara Tolusso; Gigliola Sica; Gianfranco Ferraccioli
Journal: Arthritis Res Ther Date: 2010-03-25 Impact factor: 5.156

4. Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life.

Authors: Mustafa Akif Sariyildiz; Ibrahim Batmaz; Mahmut Budulgan; Mehtap Bozkurt; Levent Yazmalar; Ahmet Inanir; Tahsin Celepkolu; Remzi Çevik
Journal: Rheumatol Int Date: 2013-01-31 Impact factor: 2.631

5. Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study.

Authors: Paul Bălănescu; Anca Lădaru; Eugenia Bălănescu; Theodor Voiosu; Cristian Băicuş; Gheorghe Andrei Dan
Journal: J Clin Lab Anal Date: 2015-09-01 Impact factor: 2.352

6. N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis.

Authors: Edoardo Rosato; Rosario Cianci; Biagio Barbano; Ginevra Menghi; Antonietta Gigante; Carmelina Rossi; Enrico M Zardi; Antonio Amoroso; Simonetta Pisarri; Felice Salsano
Journal: Acta Pharmacol Sin Date: 2009-09 Impact factor: 6.150

7. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.

Authors: Dinesh Khanna; Veronica J Berrocal; Edward H Giannini; James R Seibold; Peter A Merkel; Maureen D Mayes; Murray Baron; Philip J Clements; Virginia Steen; Shervin Assassi; Elena Schiopu; Kristine Phillips; Robert W Simms; Yannick Allanore; Christopher P Denton; Oliver Distler; Sindhu R Johnson; Marco Matucci-Cerinic; Janet E Pope; Susanna M Proudman; Jeffrey Siegel; Weng Kee Wong; Athol U Wells; Daniel E Furst
Journal: Arthritis Care Res (Hoboken) Date: 2016-02 Impact factor: 4.794

8. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.

9. Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case-control study.

Authors: P T Chan; C C Mok; K L Chan; L Y Ho
Journal: Clin Rheumatol Date: 2014-02-16 Impact factor: 2.980

10. Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.

Authors: Dimitrios Daoussis; Stamatis-Nick C Liossis; Athanassios C Tsamandas; Christina Kalogeropoulou; Alexandra Kazantzi; Chaido Sirinian; Maria Karampetsou; Georgios Yiannopoulos; Andrew P Andonopoulos
Journal: Rheumatology (Oxford) Date: 2009-05-15 Impact factor: 7.580